# DEXLANSOPRAZOLE
> **ANDA202294** · Abbreviated New Drug Application (Generic) · Sponsor: PH HEALTH · Approved 2017-04-19
## Drug
- **FDA Application Number:** ANDA202294
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DEXLANSOPRAZOLE
- **Generic name:** DEXLANSOPRAZOLE
- **Active ingredients:** DEXLANSOPRAZOLE
- **Dosage form:** CAPSULE, DELAYED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** PH HEALTH
- **Manufacturer:** Par Health USA, LLC
- **First approval:** 2017-04-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202294)
---
*AI Analytics · CC0 1.0*